Skip to main content
logo
Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
0.3132
-0.0048 (-1.51%)
At close: Jun 5, 2026, 4:00 PM EDT
0.3061
-0.0071 (-2.27%)
After-hours: Jun 5, 2026, 7:59 PM EDT

Mereo BioPharma Group Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-35.71-41.88-43.25-44.11-42.5119.25
Depreciation & Amortization
1.181.151.091.080.880.87
Stock-Based Compensation
6.937.67.395.084.674.46
Other Adjustments
1.585.362.3114.73-10.36-32.99
Change in Receivables
0.81.311.330.80.84-0.8
Changes in Accounts Payable
0.22-1.380.15-1.391.36-1.7
Changes in Accrued Expenses
-0.78-2.39-1.19---
Changes in Income Taxes Payable
---1.37-1.853.82
Changes in Other Operating Activities
-0.77-0.74-0.65---
Operating Cash Flow
-26.95-30.97-32.83-22.44-46.96-7.08
Capital Expenditures
--0.02---0.01-0.72
Purchases of Intangible Assets
-0.3-0.3-0.7---
Proceeds from Sale of Intangible Assets
-----0.15
Other Investing Activities
-0.3-1.641.820
Investing Cash Flow
--0.02-0.71.641.81-0.57
Long-Term Debt Repaid
----3.26--
Net Long-Term Debt Issued (Repaid)
----3.26--
Issuance of Common Stock
0.040.534711.88-106.24
Net Common Stock Issued (Repurchased)
0.040.534711.88-106.24
Other Financing Activities
-0.13-0.2-0.85-2.14-0.95-1.25
Financing Cash Flow
-0.10.3346.156.48-0.95104.99
Effect of Exchange Rate Changes on Cash and Cash Equivalents
0.531.85-0.230.020.18-1.58
Net Cash Flow
-27.05-30.6612.61-14.32-46.197.33
Free Cash Flow
-26.95-30.99-32.83-22.44-46.98-7.81
FCF Margin
-5390.80%-6198.20%--224.43%--15.83%
Free Cash Flow Per Share
-0.17-0.19-0.22-0.17-0.39-0.07
Levered Free Cash Flow
-35.86-45.26-43.87-31.68-39.8319.47
Unlevered Free Cash Flow
-37.82-43.49-47.98-26.86-49.48-23.03
SEC Filings: 10-K · 10-Q